Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-07 4:47 pm Purchase | 2025-09-30 | 13G | BriaCell Therapeutics Corp. BCTX | CVI Investments, Inc. | 98,944 4.900% | 98,944 (New Position) | Filing History |
| 2025-10-10 12:31 pm Purchase | 2025-08-25 | 13G | BriaCell Therapeutics Corp. Warrant BCTXZ | Plambeck Jeremy Myung Jae | 13,339 100.000% | 13,339 (New Position) | Filing History |
| 2025-07-28 11:38 am Purchase | 2025-07-15 | 13G | BriaCell Therapeutics Corp. BCTX | Iroquois Capital Management, LLC | 160,000 9.100% | 160,000 (New Position) | Filing History |
| 2025-07-22 09:59 am Purchase | 2025-07-15 | 13G | BriaCell Therapeutics Corp. BCTX | CVI Investments, Inc. | 100,000 5.700% | 64,411 (+180.99%) | Filing History |
| 2025-07-21 11:16 am Sale | 2025-06-30 | 13G | BriaCell Therapeutics Corp. BCTX | CVI Investments, Inc. | 35,589 4.900% | -13,331 (-27.25%) | Filing History |
| 2025-05-13 9:08 pm Sale | 2025-03-31 | 13G | BriaCell Therapeutics Corp. BCTX | 3i, LP | 19,001 4.900% | -17,899 (-48.51%) | Filing History |
| 2025-05-01 10:01 am Purchase | 2025-04-24 | 13G | BriaCell Therapeutics Corp. BCTX | CVI Investments, Inc. | 48,920 8.600% | 48,920 (New Position) | Filing History |
| 2025-02-10 9:02 pm Purchase | 2025-02-05 | 13G | BriaCell Therapeutics Corp. BCTX | 3i, LP | 36,900 9.900% | 36,900 (New Position) | Filing History |
| 2024-12-12 06:06 am Purchase | 2024-12-10 | 13D | BriaCell Therapeutics Corp. BCTX | L5 Capital Inc. | 26,876 10.700% | 517 (+1.96%) | Filing History |
| 2024-12-10 06:06 am Purchase | 2024-12-06 | 13D | BriaCell Therapeutics Corp. BCTX | L5 Capital Inc. | 26,359 10.500% | 767 (+3.00%) | Filing History |
| 2024-12-05 07:45 am Purchase | 2024-12-03 | 13D | BriaCell Therapeutics Corp. BCTX | L5 Capital Inc. | 25,592 10.000% | 7,573 (+42.03%) | Filing History |
| 2024-11-14 12:17 pm Sale | 2024-09-30 | 13G | BriaCell Therapeutics Corp. BCTX | CVI Investments, Inc. | 4,000 1.900% | -13,391 (-77.00%) | Filing History |
| 2024-09-16 10:22 am Purchase | 2024-09-11 | 13G | BriaCell Therapeutics Corp. BCTX | CVI Investments, Inc. | 17,391 8.500% | 17,391 (New Position) | Filing History |
| 2024-05-24 08:58 am Purchase | 2024-05-14 | 13D | BriaCell Therapeutics Corp. BCTX | L5 Capital Inc. | 18,020 14.700% | 7,820 (+76.66%) | Filing History |
| 2024-01-08 11:01 am Purchase | 2023-12-29 | 13G | BriaCell Therapeutics Corp. BCTX | Copia Fund (Cayman) LP | 5,456 5.100% | 5,456 (New Position) | Filing History |
| 2023-02-14 4:35 pm Purchase | 2022-12-31 | 13G | BriaCell Therapeutics Corp. BCTX | Lynwood Capital Management Inc. | 9,733 9.300% | 3,933 (+67.82%) | Filing History |
| 2022-08-01 07:00 am Purchase | 2022-07-20 | 13G | BriaCell Therapeutics Corp. BCTX | Lynwood Capital Management Inc. | 5,800 5.600% | 567 (+10.83%) | Filing History |
| 2022-04-25 4:05 pm Purchase | 2022-04-14 | 13G | BriaCell Therapeutics Corp. BCTX | Southwest Private Capital Inc. | 5,213 5.100% | 5,213 (New Position) | Filing History |
| 2022-02-14 3:21 pm Unchanged | 2021-12-31 | 13G | BriaCell Therapeutics Corp. BCTX | CVI Investments, Inc. | 4,000 3.600% | 0 (Unchanged) | Filing History |
| 2022-02-11 8:39 pm Purchase | 2021-12-31 | 13G | BriaCell Therapeutics Corp. BCTX | Altium Capital Management LLC | 6,000 4.700% | 2,667 (+80.00%) | Filing History |